Apolipoprotein E delivery by peritoneal implantation of encapsulated recombinant cells improves the hyperlipidaemic profile in apoE-deficient mice

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1686, Issue 3, 2005, Pages 190-199

  Tagalakis, Aristides D ^a,b   Diakonov, Ivan A ^a   Graham, Ian R ^b   Heald, Karen A ^c   Harris, Julian D ^b   Mulcahy, Jane V ^a   Dickson, George ^b   Owen, James S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Cholesterol; Gene transfer; Hypercholesterolaemia; Lipoprotein

Indexed keywords

ALGINIC ACID; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; POLYLYSINE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CHO CELL; CONTROLLED STUDY; EFFUSION; ENCAPSULATION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IN VITRO STUDY; MICROCAPSULE; MOUSE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; WILD TYPE;

ALGINATES; ANIMALS; APOLIPOPROTEINS E; CELL TRANSPLANTATION; CHO CELLS; CHOLESTEROL, HDL; CRICETINAE; CRICETULUS; HYPERLIPIDEMIAS; INJECTIONS, INTRAPERITONEAL; MICE; MICE, KNOCKOUT; MICROSPHERES; PERITONEUM;

CRICETINAE; CRICETULUS GRISEUS;

EID: 11144343281     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2004.10.001     Document Type: Article

References (68)

1. R.W. Mahley, and S.C. Rall Jr. Apolipoprotein E: far more than a lipid transport protein Annu. Rev. Genomics Hum. Genet. 1 2001 507 537
2. R.W. Mahley, and Z.S. Ji Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E J. Lipid Res. 40 1999 1 16
3. K.H. Weisgraber Apolipoprotein E: structure-function relationships Adv. Protein Chem. 45 1994 249 302
4. F.M. van Bockxmeer, C.D. Mamotte, F.A. Gibbons, V. Burke, and R.R. Taylor Angiotensin-converting enzyme and apolipoprotein E genotypes and retenosis after coronary angioplasty Circulation 92 1995 2066 2071
5. S.E. Humphries, P.J. Talmud, E. Hawe, M. Bolla, I.N. Day, and G.J Miller Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study Lancet 358 2001 115 119
6. N. Yamada, I. Inoue, M. Kawamura, K. Harada, Y. Watanabe, H. Shimano, T. Gotoda, M. Shimada, K. Kohzaki, T. Tsukada, M. Shiomi, Y. Watanabe, and Y. Yazaki Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits J. Clin. Invest. 89 1992 706 711
7. H. Shimano, N. Yamada, M. Katsuki, M. Shimada, T. Gotoda, K. Harada, T. Murase, C. Fukazawa, F. Takaku, and Y. Yazaki Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia Proc. Natl. Acad. Sci. U. S. A. 89 1992 1750 1754
8. K. Yamamoto, H. Shimano, M. Shimada, M. Kawamura, T. Gotoda, K. Harada, J. Ohsuga, Y. Yazaki, and N. Yamada Overexpression of apolipoprotein E prevents development of diabetic hyperlipidemia in transgenic mice Diabetes 44 1995 580 585
9. J.A. Piedrahita, S.H. Zhang, J.R. Hagaman, P.M. Oliver, and N. Maeda Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells Proc. Natl. Acad. Sci. U. S. A. 89 1992 4471 4475
10. J.D. Harris, I.R. Graham, S. Schepelmann, A.K. Stannard, M.L. Roberts, B.L. Hodges, V. Hill, A. Amalfitano, D.G. Hassall, J.S. Owen, and G. Dickson Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE Hum. Mol. Genet. 11 2002 43 58
11. A.L. Parker, C. Newman, S. Briggs, L. Seymour, and P.J. Sheridan Nonviral gene delivery: techniques and implications for molecular medicine Expert Rev. Mol. Med. 5 2003 1 15
12. M.D. Brown, A.G. Schätzlein, and I.F. Uchegbu Gene delivery with synthetic (non viral) carriers Int. J. Pharm. 229 2001 1 21
13. T. Athanasopoulos, J.S. Owen, D. Hassall, M.G. Dunckley, J. Drew, J. Goodman, A.D. Tagalakis, D.R. Riddell, and G. Dickson Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice Hum. Mol. Genet. 9 2000 2545 2551
14. I.T. Tai, and A.M. Sun Microencapsulation of recombinant cells: a new delivery system for gene therapy FASEB J. 7 1993 1061 1069
15. R.P. Lanza, J.L. Hayes, and W.L. Chick Encapsulated cell technology Nat. Biotechnol. 14 1996 1107 1111
16. P.L. Chang Microcapsules as bio-organs for somatic gene therapy Ann. N.Y. Acad. Sci. 831 1997 461 473
17. T.M. Chang, and S. Prakash Therapeutic uses of microencapsulated genetically engineered cells Mol. Med. Today 4 1998 221 227
18. M.J. Lysaght, and P. Aebischer Encapsulated cells as therapy Sci. Am. 280 1999 52 58
19. P.L. Chang, J.M. Van Raamsdonk, G. Hortelano, S.C. Barsoum, N.C. MacDonald, and T.L. Stockley The in vivo delivery of heterologous proteins by microencapsulated recombinant cells Trends Biotechnol. 17 1999 78 83
20. G. Orive, R.M. Hernandez, A.R. Gascon, R. Calafiore, T.M. Chang, P. De Vos, G. Hortelano, D. Hunkeler, I. Lacik, A.M. Shapiro, and J.L. Pedraz Cell encapsulation: promise and progress Nat. Med. 9 2003 104 107
21. G. Orive, R.M. Hernandez, A. Rodriguez Gascon, R. Calafiore, T.M. Chang, P. de Vos, G. Hortelano, D. Hunkeler, I. Lacik, and J.L. Pedraz History, challenges and perspectives of cell microencapsulation Trends Biotechnol. 22 2004 87 92
22. A.D. Tagalakis, I.R. Graham, D.R. Riddell, J.G. Dickson, and J.S. Owen Gene correction of the apolipoprotein (apo) E2 phenotype to wild-type apoE3 by in situ chimeraplasty J. Biol. Chem. 276 2001 13226 13230
23. P. Aebischer, N.A. Pochon, B. Heyd, N. Deglon, J.M. Joseph, A.D. Zurn, E.E. Baetge, J.P. Hammang, M. Goddard, M. Lysaght, F. Kaplan, A.C. Kato, M. Schluep, L. Hirt, F. Regli, F. Porchet, and N. De Tribolet Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF Hum. Gene Ther. 7 1996 851 860
24. S.J. Murdoch, and W.C. Breckenridge Development of a density gradient ultracentrifugation technique for the resolution of plasma lipoproteins which avoids apo E dissociation Anal. Biochem. 222 1994 427 434
25. M.J. LaDu, T.M. Pederson, D.E. Frail, C.A. Reardon, G.S. Getz, and M.T. Falduto Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid J. Biol. Chem. 270 1995 9039 9042
26. J.V. Mulcahy, D.R. Riddell, and J.S. Owen Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux Biochem. J. 377 2004 741 747
27. P. Aebischer, M. Schluep, and N. Deglon Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients Nat. Med. 2 1996 696 699
28. C. Raoul, and P. Aebischer ALS, IGF-1 and gene therapy: 'it's never too late to mend' Gene Ther. 11 2004 429 430
29. K.A. Heald, T.R. Jay, and R. Downing Prevention of antibody-mediated lysis of islets of Langerhans by alginate encapsulation: effect of capsule composition Transplant. Proc. 26 1994 1103 1104
30. Y. Sun, X. Ma, D. Zhou, I. Vacek, and A.M Sun Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression J. Clin. Invest. 98 1996 1417 1422
31. P. Soon-Shiong Treatment of type I diabetes using encapsulated islets Adv. Drug Deliv. Rev. 35 1999 259 270
32. A. Joly, J.F. Desjardins, and B. Fremond Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver Transplantation 63 1997 795 803
33. Z.C. Liu, and T.M. Chang Coencapsulation of hepatocytes and bone marrow stem cells: in vitro conversion of ammonia and in vivo lowering of bilirubin in hyperbilirubemia Gunn rats Int. J. Artif. Organs 26 2003 491 497
34. C. Hasse, A. Zielke, G. Klock, A. Schlosser, P. Barth, U. Zimmermann, H. Sitter, W. Lorenz, and M. Rothmund Amitogenic alginates: key to first clinical application of microencapsulation technology World J. Surg. 22 1998 659 665
35. P. Aebischer, P.A. Tresco, S.R. Winn, L.A. Greene, and C.B. Jaeger Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line Exp. Neurol. 111 1991 269 275
36. I. Date, T. Shingo, H. Yoshida, K. Fujiwara, K. Kobayashi, and T. Ohmoto Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: long-term primate study Cell Transplant. 9 2000 705 709
37. N. Deglon, B. Heyd, S.A. Tan, J.M. Joseph, A.D. Zurn, and P. Aebischer Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts Hum. Gene Ther. 7 1996 2135 2146
38. W.T. Cheng, B.C. Chen, S.T. Chiou, and C.M Chen Use of nonautologous microencapsulated fibroblasts in growth hormone gene therapy to improve growth of midget swine Hum. Gene Ther. 9 1998 1995 2003
39. C.J. Ross, L. Bastedo, S.A. Maier, M.S. Sands, and P.L. Chang Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells Hum. Gene Ther. 11 2000 2117 2127
40. T. Joki, M. Machluf, A. Atala, J. Zhu, N.T. Seyfried, I.F. Dunn, T. Abe, R.S. Carroll, and P.M. Black Continuous release of endostatin from microencapsulated engineered cells for tumor therapy Nat. Biotechnol. 19 2001 35 39
41. T.A. Read, D.R. Sorensen, R. Mahesparan, P.O. Enger, R. Timpl, B.R. Olsen, M.H. Hjelstuen, O. Haraldseth, and R. Bjerkvig Local endostatin treatment of gliomas administered by microencapsulated producer cells Nat. Biotechnol. 19 2001 29 34
42. R. Valdes Xenotransplantation trials Lancet 359 2002 2281
43. L. Lin, Y. Song, C. Song, P. Xu, and C. Song Successful xenotransplantation of microencapsulated newborn pig parathyroid cells in the treatment of hypoparathyroidism in rats Chin. Med. J. (Engl.) 116 2003 1161 1165
44. H. Uludag, P. De Vos, and P.A. Tresco Technology of mammalian cell encapsulation Adv. Drug Deliv. Rev. 35 2000 259 270
45. L. Cioffi, F.G. Sturtz, S. Wittmer, B. Barut, J. Smith-Gbur, V. Moore, T. Zupancic, B. Gilligan, R. Auerbach, F. Gomez, F. Chauvin, M. Antczak, D. Platika, and H.R. Snodgrass A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E Gene Ther. 6 1999 1153 1159
46. G. Wu, J. Yuan, and D.B. Hunninghake Effect of human apolipoprotein E isoforms on plasma lipids, lipoproteins and apolipoproteins in apolipoprotein E-deficient mice Atherosclerosis 141 1998 287 296
47. O.L. Francone, M. Haghpassand, J.A. Bennett, L. Royer, and J. McNeish Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport J. Lipid Res. 38 1997 813 822
48. J.S. Owen, and J.V. Mulcahy ATP-binding cassette A1 protein and HDL homeostasis Atherosclerosis Suppl. 3 2002 13 22
49. W.A. Boisvert, J. Spangenberg, and L.K. Curtiss Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation J. Clin. Invest. 96 1995 1118 1124
50. E. Regulier, B.L. Schneider, N. Deglon, Y. Beuzard, and P. Aebischer Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts Gene Ther. 5 1998 1014 1022
51. G. Hortelano, N. Xu, A. Vandenberg, J. Solera, P.L. Chang, and F.A. Ofosu Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsules Hum. Gene Ther. 10 1999 1281 1288
52. N. Deglon, V. Aubert, F. Spertini, L. Winkel, and P. Aebischer Presence of Gal-alpha1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology Xenotransplantation 10 2003 204 213
53. A. Gaumann, M. Laudes, B. Jacob, R. Pommersheim, C. Laue, W. Vogt, and J. Schrezenmeir Effect of media composition on long-term in vitro stability of barium alginate and polyacrylic acid multilayer microcapsules Biomaterials 21 2000 1911 1917
54. D. Poncelet, T. Alexakis, B. Poncelet de Smet, and R.J. Neufeld Microencapsulation within crosslinked polyethyleneimine membranes J. Microencapsul. 11 1994 31 40
55. Y. Huang, A. von Eckardstein, S. Wu, N. Maeda, and G. Assmann A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 1834 1838
56. K.A. Heald, T.R. Jay, and R. Downing Assessment of the reproducibility of alginate encapsulation of pancreatic islets using the MTT colorimetric assay Cell Transplant. 3 1994 333 337
57. A.K. Stannard, D.R. Riddell, S.M. Sacre, A.D. Tagalakis, C. Langer, A. von Eckardstein, P. Cullen, T. Athanasopoulos, G. Dickson, and J.S. Owen Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells J. Biol. Chem. 276 2001 46011 46016
58. A.H. Hasty, M.F. Linton, L.L. Swift, and S. Fazio Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance J. Lipid Res. 40 1999 1529 1538
59. S.H. Zhang, R.L. Reddick, J.A. Piedrahita, and N. Maeda Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 258 1992 468 471
60. M. Rinaldi, A.L. Catapano, P. Parrella, S.A. Ciafre, E. Signori, D. Seripa, P. Uboldi, R. Antonini, G. Ricci, M.G. Farace, and V.M. Fazio Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA Gene Ther. 7 2000 1795 1801
61. B.J. van Vlijmen, K.W. van Dijk, H.B. van't Hof, P.J. van Gorp, A. van der Zee, H. van der Boom, M.L. Breuer, M.H. Hofker, and L.M. Havekes In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158→Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice J. Biol. Chem. 271 1996 30595 30602
62. R. van Schilfgaarde, and P. De Vos Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets J. Mol. Med. 77 1999 199 205
63. K. Tsukamoto, P. Smith, J.M. Glick, and D.J. Rader Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice J. Clin. Invest. 10 1997 107 114
64. J.D. Harris, S. Schepelmann, T. Athanasopoulos, I.R. Graham, A.K. Stannard, Z. Mohri, V. Hill, D.G. Hassall, J.S. Owen, and G. Dickson Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E Gene Ther. 9 2002 21 29
65. C. Desurmont, J.M. Caillaud, F. Emmanuel, P. Benoit, J.C. Fruchart, G. Castro, D. Branellec, J.M. Heard, and N. Duverger Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice Arterioscler. Thromb. Vasc. Biol. 20 2000 435 442
66. I.H. Kim, A. Jozkowicz, P.A. Piedra, K. Oka, and L. Chan Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector Proc. Natl. Acad. Sci. U. S. A. 98 2001 13282 13287
67. A. Anilkumar, I. Lacik, and T.G. Wang A novel reactor for making uniform capsules Biotechnol. Bioeng. 75 2001 581 589
68. G. Orive, R.M. Hernandez, A.R. Gascon, M. Igartua, and J.L. Pedraz Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation Int. J. Pharm. 259 2003 57 68